Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sebastian Nijman

Associate Professor

Cancer is one of the biggest causes of death in the Western world. My group develops new approaches to study signalling networks in cancer cells and to uncover specific weaknesses that can be used for developing more effective targeted drugs and for guiding treatment decisions. We use high-throughput chemical and genetic screening approaches and haploid genetics to engineer isogenic human cancer cells and tease out chemical and genetic interactions that could be therapeutically exploited. These interactions are then studied in more detail using cell culture, mouse models, and patient samples.

Key publications

Recent publications

More publications